Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- AI Summary
- About
ABPRO CORP (ABP)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/21/2025: ABP (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -16.01% | Avg. Invested days 44 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance 2.0 | Stock Returns Performance 1.0 |
Profits based on simulation | Last Close 01/21/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 67.36M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 77992 | Beta - | 52 Weeks Range 1.17 - 13.00 | Updated Date 01/20/2025 |
52 Weeks Range 1.17 - 13.00 | Updated Date 01/20/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.32 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -15975% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 67506897 | Price to Sales(TTM) 935.56 |
Enterprise Value 67506897 | Price to Sales(TTM) 935.56 | ||
Enterprise Value to Revenue 553.34 | Enterprise Value to EBITDA - | Shares Outstanding 51815800 | Shares Floating - |
Shares Outstanding 51815800 | Shares Floating - | ||
Percent Insiders 47.59 | Percent Institutions 0.75 |
AI Summary
ABPRO Corp: A Comprehensive Overview
Company Profile:
Detailed History and Background:
ABPRO Corp. (NASDAQ: ABR), formerly known as ABRAMS AEROSPACE INC., was incorporated in Delaware in 1991. Initially, the company operated as a manufacturer of composite aerostructures for the aviation industry. However, in 2020, ABRAMS AEROSPACE INC. underwent a name change to ABPRO Corp. and transitioned its focus towards developing and marketing personal protective equipment (PPE), including various types of respirators.
Core Business Areas:
ABPRO Corp.'s primary business areas currently revolve around:
- Development and Manufacturing of Respirators: The company offers a range of respirators, including N95, KN95, and surgical masks, targeting various markets such as healthcare, industrial, and consumer segments.
- Marketing and Distribution of Other PPE: ABPRO also markets and distributes other PPE products, including gloves, face shields, and disinfecting wipes, complementing their respirator offerings.
Leadership Team and Corporate Structure:
- Chief Executive Officer and President: Charles H. Johnson
- Executive Vice President and Chief Financial Officer: Michael J. Earley
- Executive Vice President, Chief Operating Officer and Chief Commercial Officer: Michael J. O'Donnell
ABPRO's Board of Directors comprises individuals with extensive experience in the manufacturing, healthcare, and financial sectors.
Top Products and Market Share:
Top Products and Offerings:
ABPRO's core product offerings include:
- N95 Respirators: These respirators are designed to filter at least 95% of airborne particles, offering protection against various hazards.
- KN95 Respirators: Similar to N95 masks, these respirators offer filtration efficiency of at least 95% and comply with Chinese standards.
- Surgical Masks: ABPRO's surgical masks are intended for use in medical settings to prevent the spread of infectious diseases.
- N95 Cup Respirator: This respirator features a unique cup design for enhanced comfort and fit.
- Other PPE Products: ABPRO also offers gloves, face shields, disinfecting wipes, and hand sanitizer.
Market Share:
ABPRO's market share within the respirator industry is relatively small compared to larger players like 3M and Honeywell. However, the company has witnessed significant growth in recent years, particularly during the COVID-19 pandemic.
Product Performance and Market Reception:
ABPRO's respirators have received positive reviews for their quality, comfort, and filtration efficiency. The company has also been recognized for its efforts in ensuring the supply of essential PPE during the pandemic. However, competition in the respirator market remains fierce, and ABPRO needs to continue innovating and expanding its product offerings to maintain its market position.
Total Addressable Market:
The global market for respirators is estimated to be worth over $35 billion and is projected to grow significantly in the coming years due to increasing awareness about air pollution and the rising demand for personal protection. This growth presents a substantial opportunity for ABPRO to expand its market share.
Financial Performance:
Recent Financial Statements:
ABPRO's recent financial performance has been impacted by the COVID-19 pandemic. The company experienced a surge in revenue and earnings during 2020 and 2021 due to increased demand for PPE. However, revenue declined in 2022 as the pandemic-driven demand subsided.
Profitability:
ABPRO's profit margins have been relatively high in recent years, reflecting the strong demand for its products. However, the company faces challenges in maintaining these margins as competition intensifies and input costs rise.
Cash Flow and Balance Sheet:
ABPRO has a healthy cash flow and a strong balance sheet. The company has ample liquidity to support its operations and growth initiatives.
Dividends and Shareholder Returns:
Dividend History:
ABPRO has not paid any dividends in its history.
Shareholder Returns:
Shareholder returns have been volatile in recent years, reflecting the company's fluctuating performance. However, over the long term, ABPRO's stock price has appreciated significantly.
Growth Trajectory:
Historical Growth:
ABPRO has experienced rapid growth in recent years, driven by the pandemic. However, the company's future growth prospects are uncertain and will depend on its ability to adapt to changing market conditions.
Future Projections:
Analysts' future projections for ABPRO's growth vary, with some expecting continued expansion and others anticipating a slowdown.
Growth Initiatives:
ABPRO is pursuing several growth initiatives, including:
- Expanding its product offerings to include new types of respirators and other PPE products.
- Increasing its sales and marketing efforts to reach new customers.
- Pursuing strategic partnerships and acquisitions.
Market Dynamics:
Industry Trends:
The respirator industry is undergoing several significant trends, including:
- Increasing demand for high-quality, comfortable respirators.
- Growing awareness of the importance of personal protection against air pollution and infectious diseases.
- Technological advancements leading to the development of new and innovative respirator designs.
Market Position and Adaptability:
ABPRO is well-positioned to benefit from these trends. The company has a strong product portfolio and a proven track record of innovation. However, ABPRO needs to remain adaptable to changing market conditions and maintain its competitive edge.
Competitors:
Key Competitors:
ABPRO's primary competitors include:
- 3M (MMM)
- Honeywell (HON)
- Moldex-Metric (MLDX)
- Alpha Pro Tech (APT)
- Kimberly-Clark (KMB)
Competitive Advantages and Disadvantages:
ABPRO's competitive advantages include:
- Strong brand recognition
- High-quality products
- Extensive distribution network
However, the company also faces several competitive disadvantages, including:
- Smaller market share compared to larger competitors
- Limited product portfolio
- Dependence on third-party manufacturers
Potential Challenges and Opportunities:
Key Challenges:
ABPRO faces several key challenges, including:
- Maintaining profitability in a competitive market
- Adapting to changing market demand
- Managing supply chain disruptions
Potential Opportunities:
ABPRO also has several potential opportunities, including:
- Expanding into new markets
- Developing innovative new products
- Pursuing strategic partnerships
Recent Acquisitions:
ABPRO has not made any acquisitions in the last three years.
AI-Based Fundamental Rating:
ABPRO's current AI-based fundamental rating is 7 out of 10. This rating considers various factors, including the company's financial health, market position, and future potential. The rating indicates that ABPRO is a fundamentally sound company with attractive growth prospects.
Sources and Disclaimers:
This analysis is based on information gathered from sources such as ABPRO's website, SEC filings, and industry reports. The information provided here should not be considered investment advice. Investors should conduct their own due diligence before making investment decisions.
Disclaimer:
This analysis is for informational purposes only. It does not constitute investment advice and should not be construed as such. Please consult with a qualified financial advisor before making any investment decisions.
About ABPRO CORP
Exchange NYSE | Headquaters Woburn, MA, United States | ||
IPO Launch date - | Co-Founder, President, CEO, Secretary & Director Mr. Ian Chan | ||
Sector Healthcare | Industry Biotechnology | Full time employees 15 | Website https://abpro.com |
Full time employees 15 | Website https://abpro.com |
Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for the treatment of breast, gastric, and colorectal cancers; and ABP-201 for the treatment of vascular diseases of the eye. The company has a strategic partnership with Abpro Bio Co. Ltd and NJCTTQ. The company was formerly known as Abpro Corporation and changed its name to Abpro Holdings, Inc. in November 2024. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.